Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Ligand Pharmaceuticals Incorporated, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Ligand Pharmaceuticals Incorporated June 5, 202692.7%
-
Ligand Pharmaceuticals Incorporated June 9, 202593.3%
-
Ligand Pharmaceuticals Incorporated June 14, 202490.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 12, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −500 | $325.00 | $162,500 |
| Jun 5, 2026 | Ligand Pharmaceuticals Incorporated | Grant or award | +836 | — | — |
| May 13, 2026 | Ligand Pharmaceuticals Incorporated | Option exercise | +1,575 | $69.51 | $109,478 |
| May 13, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −1,575 | $223.50 | $352,013 |
| May 12, 2026 | Ligand Pharmaceuticals Incorporated | Option exercise | +459 | $69.51 | $31,905 |
| May 12, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −459 | $224.00 | $102,816 |
| May 1, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −80 | $227.37 | $18,190 |
| May 1, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −1 | $229.87 | $230 |
| May 1, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −165 | $231.87 | $38,259 |
| May 1, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −105 | $232.57 | $24,420 |
| May 1, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −116 | $234.09 | $27,154 |
| Apr 1, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −146 | $199.97 | $29,196 |
| Apr 1, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −40 | $201.24 | $8,050 |
| Apr 1, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −79 | $202.42 | $15,991 |
| Apr 1, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −43 | $202.91 | $8,725 |
Questions about John W. Kozarich
What boards is John W. Kozarich on?
John W. Kozarich sits on the board of Ligand Pharmaceuticals Incorporated.
How long has John W. Kozarich served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.